A detailed history of Edentree Asset Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Edentree Asset Management LTD holds 2,800 shares of ABBV stock, worth $504,000. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,800
Previous 2,800 -0.0%
Holding current value
$504,000
Previous $480 Million 15.18%
% of portfolio
0.16%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.33 Million - $1.51 Million
-8,300 Reduced 74.77%
2,800 $509 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $667,950 - $773,250
-5,000 Reduced 31.06%
11,100 $1.66 Billion
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $2.13 Million - $2.65 Million
16,100 New
16,100 $2.17 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Edentree Asset Management LTD Portfolio

Follow Edentree Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edentree Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edentree Asset Management LTD with notifications on news.